Reporting results for deep molecular responses in chronic myeloid leukemia

被引：2
|
作者：
Morley, A. A. [1 ]
机构：
[1] Flinders Univ & Med Ctr, Dept Haematol & Genet Pathol, Adelaide, SA, Australia
来源：
LEUKEMIA | 2016年 / 30卷 / 07期
关键词：
D O I：
10.1038/leu.2016.94
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1630 / +
页数：2
相关论文
共 50 条
  • [31] Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
    Bing Li
    Robert Peter Gale
    Zhijian Xiao
    Journal of Hematology & Oncology, 7
  • [32] The significance of early, major and stable molecular responses in chronic myeloid leukemia in the imatinib era
    Breccia, Massimo
    Alimena, Giuliana
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 79 (02) : 135 - 143
  • [33] MONITORING OF HAEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESPONSES IN CHRONIC MYELOID LEUKEMIA PATIENTS ON TKI THERAPY
    Mahmood, Rafia
    Malik, Hamid Saeed
    Suhail, Maymoona
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 : 61 - 62
  • [34] SWITCH TO GENERIC IMATINIB: IMPACT ON MOLECULAR RESPONSES AND SAFETY IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS
    Scalzulli, E.
    Porrazzo, M.
    Stocchi, F.
    Colafigli, G.
    Molica, M.
    Diverio, D.
    Latagliata, R.
    Foa, R.
    Breccia, M.
    HAEMATOLOGICA, 2019, 104 : 22 - 23
  • [35] Molecular Responses to Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Michor, Franziska
    Olshen, Adam
    Gonen, Mithat
    Jones, Dan
    Rios, Mary Beth
    O'Brien, Susan
    Cortes, Jorge
    BLOOD, 2008, 112 (11) : 1114 - 1115
  • [36] Imatinib Dose Reduction in Patients with Chronic Myeloid Leukemia in Sustained Deep Molecular Response
    Correa, Juan
    Cervantes, Francisco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S228 - S228
  • [37] Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response
    Francisco Cervantes
    Juan-Gonzalo Correa
    Isabel Pérez
    Valentín García-Gutiérrez
    Sara Redondo
    Dolors Colomer
    Antonio Jiménez-Velasco
    Juan-Luis Steegmann
    Fermín Sánchez-Guijo
    Francisca Ferrer-Marín
    Arturo Pereira
    Santiago Osorio
    Annals of Hematology, 2017, 96 : 81 - 85
  • [38] Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response
    Cervantes, Francisco
    Correa, Juan-Gonzalo
    Perez, Isabel
    Garcia-Gutierrez, Valentin
    Redondo, Sara
    Colomer, Dolors
    Jimenez-Velasco, Antonio
    Steegmann, Juan-Luis
    Sanchez-Guijo, Fermin
    Ferrer-Marin, Francisca
    Pereira, Arturo
    Osorio, Santiago
    ANNALS OF HEMATOLOGY, 2017, 96 (01) : 81 - 85
  • [39] Complete Cytogenetic Response, Not Deep Molecular Response, Is Associated With Survival in Chronic Myeloid Leukemia
    Kantarjian, Hagop
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3077 - 3077
  • [40] Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia
    Dragani, Matteo
    Rege-Cambrin, Giovanna
    Ferrero, Dario
    Abruzzese, Elisabetta
    Pregno, Patrizia
    Elena, Chiara
    Cedrone, Michele
    Santoro, Marco
    Andreani, Giacomo
    Saglio, Giuseppe
    Fava, Carmen
    LEUKEMIA & LYMPHOMA, 2019, 60 (13) : 3330 - 3332
12345